// App-Quantinova.ai

1227 : Eliminating the immunotoxicity of interleukin-12 through protease-sensitive masking

Researchers

Presenter

  • Jun Ishihara

Principal Investigators

  • Aslan Mansurov

  • Jeffrey Hubbell

Medical Centers

  • Univesity of Chicago, Chicago, USA

  • Imperial College London, London, NY

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Annexin A1

  • Interleukin 12

  • Interleukin 12A

  • L-serine

Drug/Treatment

  • IL-12

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved